abstract |
The present invention relates to a solid dispersion for oral administration with improved bioavailability, based on 100 parts by weight of rivaroxaban, 10 to 200 parts by weight of sodium lauryl sulfate; and 10 to 50 parts by weight of a water-soluble polymer; and a rivaroxaban-containing solid dispersion comprising the same, a pharmaceutical composition comprising the same, and a method for preparing them, for oral administration with improved water solubility and dissolution rate and improved bioavailability A solid dispersion is provided. |